David J Bond1, Tae Hyon Ha2, Donna J Lang3, Wayne Su3, Ivan J Torres1, William G Honer3, Raymond W Lam1, Lakshmi N Yatham4. 1. Mood Disorders Centre (DJB, IJT, RWL, LNY), Department of Psychiatry, University of British Columbia, Vancouver, Canada. 2. Bipolar Disorder Translational Research Center and Department of Psychiatry (THH), Seoul National University Bundang Hospital, Seoul, Korea. 3. Departments of Radiology and Psychiatry (DJL, WS, WGH), Centre for Complex Disorders, University of British Columbia, Vancouver, Canada. 4. Mood Disorders Centre (DJB, IJT, RWL, LNY), Department of Psychiatry, University of British Columbia, Vancouver, Canada. Electronic address: yatham@mail.ubc.ca.
Abstract
BACKGROUND: We previously reported that overweight/obese first-episode mania patients had reduced white matter (WM) and temporal lobe volumes compared with normal-weight patients. WM reductions are characteristic of early-stage bipolar disorder (BD), whereas temporal lobe reductions are frequently reported later in the illness. These findings thus suggested a testable hypothesis: that the neuropathology of BD is exacerbated with elevated body mass index (BMI). METHODS: We used voxel-based morphometry to examine the relationship between BMI and regional gray matter (GM) and WM volumes in our sample of 57 euthymic first-episode mania patients and 55 healthy subjects. We hypothesized that elevated BMI in patients, but not healthy subjects, would be associated with volume reductions in frontal, temporal, and subcortical limbic brain regions implicated in the pathophysiology of BD. RESULTS: At recovery from their first manic episode, patients with higher BMI had GM and WM reductions in the predicted emotion-generating and -regulating regions. In contrast, healthy subjects with higher BMI had reduced occipital lobe GM only. Factorial analyses confirmed significant BMI × diagnosis interactions for the WM reductions. Approximately three-quarters of patients with elevated BMI were overweight rather than obese; thus, weight-related volume reductions were detectable in patients with modestly elevated BMI. CONCLUSIONS: This is the first hypothesis-driven test of, and supporting evidence for, our theory that elevated BMI is associated with unique brain changes in BD that have a negative impact on regions believed to be vulnerable in the illness. Our results suggest a neurobiological mechanism to explain the well-validated link between obesity and illness severity in BD.
BACKGROUND: We previously reported that overweight/obese first-episode maniapatients had reduced white matter (WM) and temporal lobe volumes compared with normal-weight patients. WM reductions are characteristic of early-stage bipolar disorder (BD), whereas temporal lobe reductions are frequently reported later in the illness. These findings thus suggested a testable hypothesis: that the neuropathology of BD is exacerbated with elevated body mass index (BMI). METHODS: We used voxel-based morphometry to examine the relationship between BMI and regional gray matter (GM) and WM volumes in our sample of 57 euthymic first-episode maniapatients and 55 healthy subjects. We hypothesized that elevated BMI in patients, but not healthy subjects, would be associated with volume reductions in frontal, temporal, and subcortical limbic brain regions implicated in the pathophysiology of BD. RESULTS: At recovery from their first manic episode, patients with higher BMI had GM and WM reductions in the predicted emotion-generating and -regulating regions. In contrast, healthy subjects with higher BMI had reduced occipital lobe GM only. Factorial analyses confirmed significant BMI × diagnosis interactions for the WM reductions. Approximately three-quarters of patients with elevated BMI were overweight rather than obese; thus, weight-related volume reductions were detectable in patients with modestly elevated BMI. CONCLUSIONS: This is the first hypothesis-driven test of, and supporting evidence for, our theory that elevated BMI is associated with unique brain changes in BD that have a negative impact on regions believed to be vulnerable in the illness. Our results suggest a neurobiological mechanism to explain the well-validated link between obesity and illness severity in BD.
Authors: Scott C Fears; Remmelt Schür; Rachel Sjouwerman; Susan K Service; Carmen Araya; Xinia Araya; Julio Bejarano; Emma Knowles; Juliana Gomez-Makhinson; Maria C Lopez; Ileana Aldana; Terri M Teshiba; Zvart Abaryan; Noor B Al-Sharif; Linda Navarro; Todd A Tishler; Lori Altshuler; George Bartzokis; Javier I Escobar; David C Glahn; Paul M Thompson; Carlos Lopez-Jaramillo; Gabriel Macaya; Julio Molina; Victor I Reus; Chiara Sabatti; Rita M Cantor; Nelson B Freimer; Carrie E Bearden Journal: Brain Date: 2015-05-05 Impact factor: 13.501
Authors: S L McElroy; D E Kemp; E S Friedman; N A Reilly-Harrington; L G Sylvia; J R Calabrese; D J Rabideau; T A Ketter; M E Thase; V Singh; M Tohen; C L Bowden; E E Bernstein; B D Brody; T Deckersbach; J H Kocsis; G Kinrys; W V Bobo; M Kamali; M G McInnis; A C Leon; S Faraone; A A Nierenberg; R C Shelton Journal: Acta Psychiatr Scand Date: 2015-06-26 Impact factor: 6.392
Authors: Sean R McWhinney; Christoph Abé; Martin Alda; Francesco Benedetti; Erlend Bøen; Caterina Del Mar Bonnin; Tiana Borgers; Katharina Brosch; Erick J Canales-Rodríguez; Dara M Cannon; Udo Dannlowski; Ana M Diaz-Zuluaga; Lorielle Dietze; Torbjørn Elvsåshagen; Lisa T Eyler; Janice M Fullerton; Jose M Goikolea; Janik Goltermann; Dominik Grotegerd; Bartholomeus C M Haarman; Tim Hahn; Fleur M Howells; Martin Ingvar; Tilo T J Kircher; Axel Krug; Rayus T Kuplicki; Mikael Landén; Hannah Lemke; Benny Liberg; Carlos Lopez-Jaramillo; Ulrik F Malt; Fiona M Martyn; Elena Mazza; Colm McDonald; Genevieve McPhilemy; Sandra Meier; Susanne Meinert; Tina Meller; Elisa M T Melloni; Philip B Mitchell; Leila Nabulsi; Igor Nenadic; Nils Opel; Roel A Ophoff; Bronwyn J Overs; Julia-Katharina Pfarr; Julian A Pineda-Zapata; Edith Pomarol-Clotet; Joaquim Raduà; Jonathan Repple; Maike Richter; Kai G Ringwald; Gloria Roberts; Alex Ross; Raymond Salvador; Jonathan Savitz; Simon Schmitt; Peter R Schofield; Kang Sim; Dan J Stein; Frederike Stein; Henk S Temmingh; Katharina Thiel; Sophia I Thomopoulos; Neeltje E M van Haren; Holly Van Gestel; Cristian Vargas; Eduard Vieta; Annabel Vreeker; Lena Waltemate; Lakshmi N Yatham; Christopher R K Ching; Ole A Andreassen; Paul M Thompson; Tomas Hajek Journal: Bipolar Disord Date: 2021-12-16 Impact factor: 5.345
Authors: Tomas Hajek; Cynthia Calkin; Ryan Blagdon; Claire Slaney; Rudolf Uher; Martin Alda Journal: Neuropsychopharmacology Date: 2014-06-19 Impact factor: 7.853
Authors: Anderson M Winkler; Matthew A Webster; Diego Vidaurre; Thomas E Nichols; Stephen M Smith Journal: Neuroimage Date: 2015-06-11 Impact factor: 6.556
Authors: Sabrina K Syan; Luciano Minuzzi; Mara Smith; Dustin Costescu; Olivia R Allega; Geoffrey B C Hall; Benicio N Frey Journal: Front Psychiatry Date: 2018-01-10 Impact factor: 4.157
Authors: D J Bond; L E Silveira; E L MacMillan; I J Torres; D J Lang; W Su; W G Honer; R W Lam; L N Yatham Journal: Transl Psychiatry Date: 2017-03-28 Impact factor: 6.222